Clinical Monograph: IroNexa™ (Ferrous Bisglycinate, Folic Acid, Zinc & Methylcobalamin).
​IroNexa™ Tablets is a high-potency hematinic formulation engineered to address iron deficiency and megaloblastic anemias. By utilizing an amino acid chelate (Ferrous Bisglycinate) alongside essential co-enzymes, IroNexa™ provides superior elemental iron delivery with minimal gastrointestinal disruption.
​Pharmacodynamics & Mechanism of Action
​IroNexa™ operates through a synergistic metabolic pathway to restore.

Hematological parameters:
​Advanced Chelation Technology: Ferrous Bisglycinate is a neutrally charged molecule that does not dissociate in the stomach. This prevents the iron from reacting with dietary phytates and tannins, allowing for maximum absorption in the duodenum via the dipeptide pathway.

​DNA Synthesis & Cell Maturation: Methylcobalamin (the active form of B12) and Folic Acid act as essential cofactors in the methionine cycle. They are critical for the methylation of homocysteine and the synthesis of thymidylate, which is required for the proper maturation of normoblasts into functional erythrocytes.

​Immunometabolism Support: Zinc Bisglycinate provides a highly bioavailable source of zinc, which is necessary for the activity of over 300 enzymes, including those responsible for hemoglobin synthesis and immune cell proliferation. Therapeutic Indications
​IroNexa™ is clinically indicated for the management of: ​Iron Deficiency Anemia (IDA): For rapid elevation of hemoglobin and restoration of skeletal and hepatic ferritin stores.
​Megaloblastic Anemia: Addressing deficiencies in Vitamin B12 and Folic Acid that lead to impaired red blood cell production.
​Pregnancy & Post-Surgical Recovery: Supporting increased maternal-fetal iron demands and replenishing blood loss during the perioperative period.
​Pharmaceutical Characteristics ​Active Ingredients: Ferrous Bisglycinate 60mg+Folic Acid 1 mg+ Zinc Bisglycinate 15mg+ Methylcobalamin 500 mcg.
​Dosage Form: Oral Tablet.
​Pharmacological Class: Hematinic / Nutritional Supplement.
​Packaging: 1 x 10 Tablets in a premium gold-standard blister strip.
​Clinical Considerations ​Administration: One tablet daily or as directed by the physician. Optimal absorption occurs when taken between meals.
​Safety Profile: The chelated form of iron significantly reduces the common side effects of constipation, nausea, and epigastric pain associated with ferrous sulfate.
​Regulatory Classification: Dietary Supplement / Nutraceutical.
​Storage: Store in a cool, dark, and dry place. Keep out of reach of children.